Enterprise Value
119.4M
Cash
70.21M
Avg Qtr Burn
-23.53M
Short % of Float
13.89%
Insider Ownership
1.69%
Institutional Own.
33.21%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Monovalent Norovirus Vaccine Details Infectious disease, Norovirus | Phase 2 Data readout | |
Oral Bivalent Norovirus Vaccine Details Infectious disease, Norovirus | Phase 2 Data readout | |
VXA-A1.1 Details Influenza | Phase 2 Update | |
VXA-CoV2-1 Details COVID-19 | Phase 1 Update |